Twenty years of MOPP therapy for Hodgkin's disease.
暂无分享,去创建一个
[1] E. Jaffe,et al. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Johnston,et al. Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin , 1985, Cancer.
[3] W. Hryniuk,et al. The importance of dose intensity in chemotherapy of metastatic breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Deakin,et al. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] T. Lister,et al. The treatment of stage IIIA Hodgkin's disease. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Coltman,et al. Comparison of adriamycin‐containing chemotherapy (MOP‐BAP) with MOPP‐bleomycin in the management of advanced Hodgkin‐s disease a southwest oncology group study , 1983, Cancer.
[7] J. Armitage,et al. Reasons for failure of MOPP to cure Hodgkin's disease The importance of dose and schedule , 1982, American journal of clinical oncology.
[8] D. Longo,et al. Chemotherapy for Hodgkin's disease: the remaining challenges. , 1982, Cancer treatment reports.
[9] A. Santoro,et al. Alternating drug combinations in the treatment of advanced Hodgkin's disease. , 1982, The New England journal of medicine.
[10] S. Rosenberg,et al. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.
[11] J. Yarnold,et al. Factors affecting relapse following chemotherapy for Hodgkin's disease. , 1982, Clinical radiology.
[12] V. Devita,et al. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. , 1980, Annals of internal medicine.
[13] A. Dawson,et al. Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease. , 1980, British journal of clinical pharmacology.
[14] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[15] D. Rosenthal,et al. An evaluation of total nodal irradiation as treatment for stage III a Hodgkin's disease , 1979, Cancer.
[16] P. Mauch,et al. The significance of mediastinal involvement in early stage Hodgkin's disease , 1978, Cancer.
[17] E. Glatstein,et al. Hematologic neoplasia in patients treated for Hodgkin's disease. , 1977, The New England journal of medicine.
[18] S. Rosenberg,et al. Prednisone in MOPP chemotherapy for Hodgkin's disease. , 1976, British medical journal.
[19] V. Devita,et al. Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation. , 1976, International journal of radiation oncology, biology, physics.
[20] R. Dorfman,et al. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's disease , 1975, Cancer.
[21] R. Castellino,et al. Latent radiation injury of lungs or heart activated by steroid withdrawal. , 1974, Annals of internal medicine.
[22] E. Gehan,et al. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. , 1973, Annals of internal medicine.
[23] J. Bull,et al. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients , 1973, Cancer.
[24] V. Devita,et al. Maintenance chemotherapy for advanced Hodgkin's disease in remission. , 1973, Lancet.
[25] L. H. Greenberg,et al. Combination chemotherapy of Hodgkin's disease in private practice. , 1972, JAMA.
[26] D. Cox. Regression Models and Life-Tables , 1972 .
[27] D. Cox,et al. The analysis of binary data , 1971 .
[28] V. Devita,et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.
[29] R. Lukes,et al. The pathology and nomenclature of Hodgkin's disease. , 1966, Cancer research.
[30] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[31] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .